JASPER THERAPEUTICS, INC. Share-based Payment Arrangement, Exercise of Option, Tax Benefit
JASPER THERAPEUTICS, INC. (JSPR) reported Share-based Payment Arrangement, Exercise of Option, Tax Benefit of $100.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions · last filed 2023-08-11
- JASPER THERAPEUTICS, INC. share-based payment arrangement, exercise of option, tax benefit for the quarter ending 2023-06-30 was $0.00.
- JASPER THERAPEUTICS, INC. share-based payment arrangement, exercise of option, tax benefit for the quarter ending 2023-03-31 was $100.00K.
| Period end | Share-based Payment Arrangement, Exercise of Option, Tax Benefit 3 month | Share-based Payment Arrangement, Exercise of Option, Tax Benefit 6 month | Share-based Payment Arrangement, Exercise of Option, Tax Benefit 9 month |
|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $100.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-12 | ||
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |